HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy

Blood

Volumn 118, Issue 1, 2011, Pages 44-49

  Lanoy, Emilie ^a,b   Rosenberg, Philip S ^c   Fily, Fabien ^d   Lascaux, Anne Sophie ^e   Martinez, Valerie ^f   Partisani, Maria ^g   Poizot Martin, Isabelle ^h   Rouveix, Elisabeth ⁱ   Engels, Eric A ^c   Costagliola, Dominique ^a,b,j   Goedert, James J ^c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f HÔPITAL ANTOINE BÉCLÈRE   (France)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h HÔPITAL SAINTE MARGUERITE   (France)

ⁱ HÔPITAL AMBROISE PARÉ   (France)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DISEASE ASSOCIATION; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION; VIRUS LOAD;

EID: 79960121814     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-339275     Document Type: Article

References (35)

1. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20(12): 1645-1654.
2. Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;21(18): 3447-3453. (Pubitemid 46594077)
3. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351(9119):1833-1839. (Pubitemid 28279706)
4. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108(12):3786-3791. (Pubitemid 44864560)
5. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009;27(6):884-890.
6. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008; 148(10):728-736.
7. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425-432. (Pubitemid 40528605)
8. Clifford GM, Rickenbach M, Lise M, et al. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood. 2009;113(23):5737-5742.
9. Carbone A, Gloghini A, Serraino D, Spina M. HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS. 2009;4(1):3-10.
10. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008; 123(1):187-194. (Pubitemid 351705208)
11. Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009;10(12):1152-1159.
12. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr. 2003;32(5):527-533. (Pubitemid 36423125)
13. Reekie J, Kosa C, Engsig F, et al. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer. 2010;116(22): 5306-5315.
14. Robbins GK, Spritzler JG, Chan ES, et al. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis. 2009; 48(3):350-361.
15. Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(4):251-261.
16. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18(12):1615-1627. (Pubitemid 39095778)
17. Tassie JM, Gasnault J, Bentata M, et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS. 1999;13(14): 1881-1887.
18. Ancelle-Park R. Expanded European AIDS case definition. Lancet. 1993;341(8842):441. (Pubitemid 23048185)
19. World Health Organization. ICD-9: International Statistical Classification of Diseases (Revision 1995). Geneva: WHO; 1977.
20. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. Geneva: WHO; 1993.
21. Grabar S, Kousignian I, Sobel A, et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS. 2004; 18(15):2029-2038.
22. Wu H, Kuritzkes DR, McClernon DR, et al. Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points. J Infect Dis. 1999;179(4):799-807. (Pubitemid 29159324)
23. Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD. Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(1):20-26.
24. Baráth S, Aleksza M, Keresztes K, et al. Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma. Acta Haematol. 2006;116(3):181-185. (Pubitemid 44532962)
25. Franzke A, Koenecke C, Geffers R, et al. Classical Hodgkin's lymphoma: molecular evidence for specific alterations in circulating T lymphocytes. Tumour Biol. 2006;27(6):329-333. (Pubitemid 44646227)
26. Marshall NA, Christie LE, Munro LR, et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood. 2004;103(5):1755-1762. (Pubitemid 38268969)
27. Tullgren O, Grimfors G, Holm G, et al. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up. Cancer. 1991;68(4):768-775.
28. Hnátková M, Mocikova H, Trneny M, Zivny J. The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/ TARC. Prague Med Rep. 2009;110(1):35-41.
29. Peh SC, Kim LH, Poppema S. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol. 2001;25(7):925-929. (Pubitemid 32594986)
30. Romagnani S, Del Prete GF, Maggi E, et al. Displacement of T lymphocytes with the 'Helper/ Inducer' phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin's disease. Scand J Haematol. 1983;31(4):305-314. (Pubitemid 13005168)
31. Niens M, Visser L, Nolte IM, et al. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. Br J Haematol. 2008;140(5):527-536. (Pubitemid 351230079)
32. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis. 2006;42(3):418-427. (Pubitemid 43122323)
33. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27-34.
34. Bohlius J, Schmidlin K, Costagliola D, et al. Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. AIDS. 2009;23(15):2029-2037.
35. Bohlius J, Schmidlin K, Costagliola D, et al. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther. 2009;14(8):1065-1074.